APS Annual Meeting at Experimental Biology

Novel Therapeutic Approaches to Cardiovascular and Metabolic Disease

Featured Topic — Wednesday, April 28, 2021 — 2:00 PM - 3:30 PM — Virtual Session, Room APS-6
Cardiovascular Section — Chair: Ryan A. Harris — Co-Chair: Camila Manrique

Cardiovascular disease (CVD) remains the leading cause of death in the US.  Many co-morbid conditions to CVD exist, including metabolic disorders such as diabetes, obesity, and lipidemia.   Most importantly, the presence of metabolic disorders accelerates the risk for developing CVD and there are emerging data that demonstrate sex plays an important role.  Potential mechanisms for the increased risk for CVD include elevated inflammation and oxidative stress; however, many other physiological pathways have been implicated. Understanding the link between metabolic disorders and CVD will lead to the development of novel therapeutic approaches that can help reduce the risk and overall prevalence of heart disease. 

Host Societies

Copyright © 2021 Experimental Biology (EB) | Experimental Biology® is a federally registered trademark of EB.